Project Details
Description
BRIDGE aims to enhance healthcare innovation in Europe by developing a comprehensive framework for designing and operationalizing regulatory sandboxes. By addressing current regulatory limitations and engaging all stakeholders while ensuring compliance, the project seeks to create adaptable, fit-for-purpose methodologies that strengthen the regulatory ecosystem's capacity to promote healthcare innovation.
The project’s objectives include identifying and analysing existing regulatory sandboxes across various domains and maturity levels, to determine how their modules can complement current healthcare regulations. BRIDGE will develop a horizon scanning methodology to continuously identify emerging technologies that challenge existing regulatory systems, analyzing their requirements for potential inclusion in regulatory sandboxes to ensure adaptability within an evolving innovation ecosystem.
Through multi-stakeholder consultations, BRIDGE will elaborate and assess case studies, as well as develop operational checklists for module design and evidence packages to guide tailored sandbox launches. The project will also develop the Modular Operational Sandbox for Healthcare Innovation and Compliance (MOSAIC), an architectural model with interconnected modules featuring detailed functional specifications and mapped information flows aligned with specific case studies.
Additionally, BRIDGE will engage key stakeholders—including regulatory bodies, industry consortia, HTA bodies, payers, healthcare providers, and patients—in an in-depth analysis, consultation, and consensus-building process to ensure the sandbox approach is comprehensive, functional, and adaptable to future advancements. Finally, the project will deliver comprehensive recommendations for the sandbox methodology’s end-to-end operations, encompassing legal, compliance, policy, and regulatory outputs to provide a robust implementation framework.
| Acronym | BRIDGE |
|---|---|
| Status | Active |
| Effective start/end date | 1/11/25 → 31/10/28 |
Collaborative partners
- VTT Technical Research Centre of Finland
- empirica Kommunikations- und Technologieforschung GmbH
- Flemish Institute for Technological Research (VITO) (lead)
- Lilly Deutschland GmbH
- EuroScan International Network e.V.
- Msd R&d Innovation Centre Limited
- Sanofi-Aventis Deutschland GmbH
- Sanofi Winthrop Industrie SA
- Takeda Pharmaceuticals International AG
- Teva Pharmaceutical Industries Ltd
- Novartis Pharma AG
- European Federation of Pharmaceutical Industries and Associations
- University Medical Center Groningen
- Merck Sharp & Dohme (MSD)
- Merckle GmbH
- F. Hoffmann-La Roche AG
- CSL Behring GmbH
- Merck, Sharp & Dohme de España S.A.
- Merck KGaA
- European Association for Medical devices of Notified Bodies
- Astellas Pharma Europe BV
- Pfizer Healthcare Ireland Unlimited Company
- Biogen Idec Ltd
- Charité Universitätsmedizin Berlin
- Pfizer Inc.
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
- Merck Serono Ltd.
- Sanofi Pasteur SA
- Sanofi-Aventis Recherche et Développement S.A.
- Novo Nordisk A/S
- Eli Lilly & Co Ltd.
- Fundación Pública Andaluza Progreso y Salud M.P.
- Eli Lilly and Company
- European Medicines Agency (EMA)
- European Institute for Innovation through Health Data
- Janssen Pharmaceutica NV
- Université Bourgogne Europe
- Pfizer Ltd.
- Technische Universität Dresden (TUD)
- MSD Europe Belgium
- Merck Healthcare KGaA
Funding category
- Horizon Europe
Keywords
- HORIZON-JU-IHI-2024-08-03-two-stage
- ecosystems